Bri-Chem Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	75.6	83.07	106.04	104.51	60.4
Revenue Growth (YoY)	-8.99%	-21.66%	1.46%	73.02%	33.77%
Cost of Revenue	61.06	68.67	87.31	84.32	48.16
Gross Profit	14.54	14.4	18.73	20.2	12.24
Selling, General & Admin	11.31	12.04	12.79	12.24	7.8
Operating Expenses	12	15.22	14.32	13.88	9.4
Operating Income	2.53	-0.82	4.41	6.32	2.85
Interest Expense	-2.83	-3.37	-3.88	-2.56	-1.7
Currency Exchange Gain (Loss)	0.5	-0.79	0.56	-0.65	0.14
EBT Excluding Unusual Items	0.2	-4.97	1.09	3.12	1.29
Asset Writedown	-	-	-	0.89	-
Other Unusual Items	-	-	0.32	0.61	-
Pretax Income	0.2	-4.97	1.41	4.62	1.29
Income Tax Expense	-0.78	-1.12	0.5	-4.02	-0.03
Net Income	0.98	-3.85	0.91	8.64	1.32
Net Income to Common	0.98	-3.85	0.91	8.64	1.32
Net Income Growth	-	-	-89.48%	556.48%	-
Shares Outstanding (Basic)	24	26	26	26	24
Shares Outstanding (Diluted)	24	27	27	27	27
Shares Change (YoY)	-7.75%	-	-0.11%	-2.50%	13.83%
EPS (Basic)	0.04	-0.15	0.03	0.33	0.06
EPS (Diluted)	0.04	-0.15	0.03	0.33	0.05
EPS Growth	-	-	-90.83%	553.98%	-
Free Cash Flow	10.56	9.97	12	-10.67	-9.26
Free Cash Flow Per Share	0.43	0.38	0.45	-0.40	-0.34
Gross Margin	19.23%	17.34%	17.66%	19.32%	20.27%
Operating Margin	3.35%	-0.98%	4.16%	6.05%	4.71%
Profit Margin	1.29%	-4.64%	0.86%	8.27%	2.18%
Free Cash Flow Margin	13.98%	12.01%	11.32%	-10.21%	-15.33%
EBITDA	3.68	-0.2	5.08	6.92	3.32
EBITDA Margin	4.87%	-0.24%	4.79%	6.62%	5.50%
D&A For EBITDA	1.15	0.61	0.67	0.6	0.48
EBIT	2.53	-0.82	4.41	6.32	2.85
EBIT Margin	3.35%	-0.98%	4.16%	6.05%	4.71%
Effective Tax Rate	-	-	35.36%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.